These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 28291714)
1. Analysis of the RENAL and mRENAL Scores and the Relative Importance of Their Components in the Prediction of Complications and Local Progression after Percutaneous Renal Cryoablation. Mouli SK; McDevitt JL; Su YK; Ragin AB; Gao Y; Nemcek AA; Lewandowski RJ; Salem R; Sato KT J Vasc Interv Radiol; 2017 Jun; 28(6):860-867. PubMed ID: 28291714 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery. Morgan MA; Roberts NR; Pino LA; Trabulsi EJ; Brown DB; Gomella LG; Lallas CD Can J Urol; 2013 Oct; 20(5):6933-7. PubMed ID: 24128832 [TBL] [Abstract][Full Text] [Related]
4. Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications. Blute ML; Okhunov Z; Moreira DM; George AK; Sunday S; Lobko II; Vira MA BJU Int; 2013 Apr; 111(4 Pt B):E181-5. PubMed ID: 23107011 [TBL] [Abstract][Full Text] [Related]
5. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous Cryoablation for the Treatment of Primary and Metastatic Lung Tumors: Identification of Risk Factors for Recurrence and Major Complications. McDevitt JL; Mouli SK; Nemcek AA; Lewandowski RJ; Salem R; Sato KT J Vasc Interv Radiol; 2016 Sep; 27(9):1371-1379. PubMed ID: 27321886 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift? Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831 [TBL] [Abstract][Full Text] [Related]
8. sABLATE: a simplified ABLATE score for prediction of complications and outcome in percutaneous thermal ablation of renal lesions. Papa M; Biondetti P; Colombo R; Ierardi AM; Angileri SA; Lucignani G; Boeri L; Montanari E; Cardone G; Scagnelli P; Carrafiello G Med Oncol; 2021 Sep; 38(10):126. PubMed ID: 34495438 [TBL] [Abstract][Full Text] [Related]
9. Can RENAL and PADUA nephrometry indices predict complications of laparoscopic cryoablation for clinical stage T1 renal tumors? Lagerveld BW; Brenninkmeijer M; van der Zee JA; van Haarst EP J Endourol; 2014 Apr; 28(4):464-71. PubMed ID: 24228738 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous cryoablation of masses in a solitary kidney. Weisbrod AJ; Atwell TD; Frank I; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW AJR Am J Roentgenol; 2010 Jun; 194(6):1620-5. PubMed ID: 20489104 [TBL] [Abstract][Full Text] [Related]
17. Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors. De Cobelli F; Papa M; Panzeri M; Colombo M; Steidler S; Ambrosi A; Cao R; Gusmini S; Marra P; Capitanio U; Bertini R; Venturini M; Losa A; Gaboardi F; Montorsi F; Cardone G Cardiovasc Intervent Radiol; 2020 Jan; 43(1):76-83. PubMed ID: 31451888 [TBL] [Abstract][Full Text] [Related]